How much benefit will this bring to students? HPV vaccine is a cervical cancer vaccine, and the incidence of cervical cancer ranks second among female malignant tumors. The number of new cases in China is about135,000 every year. Because of the death of cervical cancer, the number of more than 50 thousand people is rising, and there is a trend of youthfulness. Using this vaccine to prevent cervical cancer not only gives parents a reassurance, but also reduces the number of cervical cancer, which is the best policy to prevent and control cervical cancer.
The practicability of the vaccine. Domestic bivalent HPV vaccine was developed and marketed by researchers from Xiamen University and Yangshengtang in 18. Domestic epidemiological research data show that the prevention rate of bivalent vaccine for domestic population infection can reach 84.5%, which is higher than the global average. For women who have never been infected with spleen and stomach once, bivalent vaccine for preventing cervical cancer can fully meet their needs. Therefore, the best time for HPV vaccination is 9- 14 years old.
Other cities should also improve their policies in time. Cervical cancer is on the rise, and it is younger. Nearly 1/3 people died of cervical cancer. Other cities should also vigorously support and implement this policy. This policy is practical and can make people feel the love from the country and society everywhere. This policy is practical and can effectively prevent cervical cancer. Vaccination against cervical cancer among primary and secondary school students can also spread effectively, making people pay attention to cervical cancer.